Nutrien (TSE:NTR – Get Free Report) was upgraded by analysts at Raymond James from a “hold” rating to a “moderate buy” rating in a report released on Tuesday,Zacks.com reports. Raymond James also issued estimates for Nutrien’s Q4 2024 earnings at $0.39 EPS and FY2024 earnings at $4.79 EPS.
A number of other equities analysts have also recently commented on the company. Wells Fargo & Company cut Nutrien from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 24th. UBS Group cut Nutrien from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 10th. Finally, The Goldman Sachs Group downgraded shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 10th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, Nutrien presently has a consensus rating of “Hold” and a consensus price target of C$64.50.
Get Our Latest Stock Report on Nutrien
Nutrien Trading Down 1.6 %
Insider Buying and Selling at Nutrien
In related news, Director Keith Martell purchased 1,250 shares of the stock in a transaction dated Thursday, September 19th. The stock was bought at an average cost of C$65.23 per share, for a total transaction of C$81,537.50. Also, Senior Officer Mark Thompson acquired 3,155 shares of Nutrien stock in a transaction that occurred on Wednesday, September 25th. The stock was acquired at an average cost of C$63.79 per share, for a total transaction of C$201,257.45. Insiders bought a total of 5,390 shares of company stock worth $346,265 over the last three months. Corporate insiders own 0.03% of the company’s stock.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Recommended Stories
- Five stocks we like better than Nutrien
- Election Stocks: How Elections Affect the Stock Market
- Stellantis Stock Falls as CEO Departs: What Investors Should Know
- What is MarketRank™? How to Use it
- 2 Stock Picks for Year-End: 1 to Keep, 1 to Cut
- What Are Dividend Challengers?
- 2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.